The current clinical practice is to discontinue statin when the liver enzymes
have increased to more than three times the upper limit of normal. Although
zetia on its own
does not generally cause liver enzyme abnormalities, it might potentiate the enzyme abnormalities, when coadministered with a statin.
Generally, when that happens, physicians would generally withdraw the statin or both medications, depending on the extent of enzyme elevation.